文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

评价多学科综合治疗方法与功能性胃肠病(FGIDs)标准护理模式:一项匹配队列研究。

Evaluation of a Multidisciplinary Integrated Treatment Approach Versus Standard Model of Care for Functional Gastrointestinal Disorders (FGIDS): A Matched Cohort Study.

机构信息

Faculties of Medicine and Health and Behavioural Sciences, University of Queensland/TRI, Brisbane, QLD, Australia.

Gastroenterology and Hepatology, Princess Alexandra Hospital, Brisbane, QLD, Australia.

出版信息

Dig Dis Sci. 2022 Dec;67(12):5593-5601. doi: 10.1007/s10620-022-07464-1. Epub 2022 Apr 1.


DOI:10.1007/s10620-022-07464-1
PMID:35362835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9652261/
Abstract

BACKGROUND: Functional gastrointestinal disorders (FGID) are linked to a variety of potential causes, and treatments include reassurance, life-style (including diet), psychological, or pharmacologic interventions. AIMS: To assess whether a multidisciplinary integrated treatment approach delivered in a dedicated integrated care clinic (ICC) was superior to the standard model of care in relation to the gastrointestinal symptom burden. METHODS: A matched cohort of 52 consecutive patients with severe manifestation of FGID were matched with 104 control patients based upon diagnosis, gender, age, and symptom severity. Patients in the ICC received structured assessment and 12-weeks integrated treatment sessions provided as required by gastroenterologist and allied health team. Control patients received standard medical care at the same tertiary center with access to allied health services as required but no standardized interprofessional team approach. Primary outcome was reduction in gastrointestinal symptom burden as measured by the Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS). Secondary outcome was reduction in anxiety and depressive symptoms as measured by the Hospital Anxiety and Depression Scale (HADS). RESULTS: Mixed models estimated the within ICC change in SAGIS total as -9.7 (95% CI -13.6, -5.8; p < 0.0001), compared with -1.7 (95% CI -4.0, 0.6; p = 0.15) for controls. The difference between groups reached statistical significance, -7.6 (95% CI -11.4, -3.8; p < 0.0001). Total HADS scores in ICC patients were 3.4 points lower post-intervention and reached statistical significance (p = 0.001). CONCLUSION: This matched cohort study demonstrates superior short-term outcomes of FGID patients in a structured multidisciplinary care setting as compared to standard care.

摘要

背景:功能性胃肠病(FGID)与多种潜在病因相关,治疗方法包括安慰、生活方式(包括饮食)、心理或药物干预。

目的:评估在专门的综合护理诊所(ICC)中提供的多学科综合治疗方法是否优于标准护理模式,在胃肠道症状负担方面是否具有优势。

方法:对 52 例 FGID 严重表现的连续患者进行了匹配队列研究,根据诊断、性别、年龄和症状严重程度与 104 例对照患者进行了匹配。ICC 中的患者接受了结构化评估和 12 周的综合治疗,由胃肠病学家和联合健康团队根据需要提供。对照患者在同一三级中心接受标准医疗护理,并根据需要获得联合健康服务,但没有标准化的跨专业团队方法。主要结局是通过胃肠道症状结构化评估量表(SAGIS)测量的胃肠道症状负担的减少。次要结局是通过医院焦虑和抑郁量表(HADS)测量的焦虑和抑郁症状的减少。

结果:混合模型估计 ICC 内 SAGIS 总分的变化为-9.7(95%CI-13.6,-5.8;p<0.0001),而对照组为-1.7(95%CI-4.0,0.6;p=0.15)。组间差异具有统计学意义,-7.6(95%CI-11.4,-3.8;p<0.0001)。ICC 患者的总 HADS 评分在干预后降低了 3.4 分,具有统计学意义(p=0.001)。

结论:这项匹配队列研究表明,与标准护理相比,FGID 患者在结构化多学科护理环境中具有更好的短期结局。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/9652261/8fefff11961a/10620_2022_7464_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/9652261/b467eabd45cc/10620_2022_7464_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/9652261/92698d5702e2/10620_2022_7464_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/9652261/8238f8bc04f7/10620_2022_7464_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/9652261/55293f63b077/10620_2022_7464_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/9652261/8fefff11961a/10620_2022_7464_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/9652261/b467eabd45cc/10620_2022_7464_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/9652261/92698d5702e2/10620_2022_7464_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/9652261/8238f8bc04f7/10620_2022_7464_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/9652261/55293f63b077/10620_2022_7464_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/380c/9652261/8fefff11961a/10620_2022_7464_Fig5_HTML.jpg

相似文献

[1]
Evaluation of a Multidisciplinary Integrated Treatment Approach Versus Standard Model of Care for Functional Gastrointestinal Disorders (FGIDS): A Matched Cohort Study.

Dig Dis Sci. 2022-12

[2]
Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial.

Lancet Gastroenterol Hepatol. 2020-7-14

[3]
Long-Term Outcome of Multidisciplinary Versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders: A Randomized Trial.

Clin Gastroenterol Hepatol. 2022-9

[4]
Comprehensive psychological intervention to improve outcome in functional gastrointestinal disorder: a cohort study.

Singapore Med J. 2015-7

[5]
Defining Optimal Care for Functional Gut Disorders - Multi-Disciplinary Versus Standard Care: A Randomized Controlled Trial Protocol.

Contemp Clin Trials. 2019-8-19

[6]
The spectrum of functional gastrointestinal disorders in a tertiary referral clinic in Ireland.

Ir J Med Sci. 2011-9-24

[7]
Multicenter study of gastroenterologists' ability to identify anxiety and depression in a new patient encounter and its impact on diagnosis.

J Clin Gastroenterol. 2008-7

[8]
Delivery of care for functional gastrointestinal disorders: A systematic review.

J Gastroenterol Hepatol. 2019-9-3

[9]
Performance of an algorithm-based approach to the diagnosis and management of functional gastrointestinal disorders: A pilot trial.

Neurogastroenterol Motil. 2017-11-2

[10]
Non-pharmacological management of abdominal pain-related functional gastrointestinal disorders in children.

World J Pediatr. 2016-11

引用本文的文献

[1]
The Bidirectional Relationship Between FGIDs and Anxiety: Pathophysiological Mechanisms and New Therapeutic Strategies.

Actas Esp Psiquiatr. 2025-8

[2]
Breaking the cycle: Psychological and social dimensions of pediatric functional gastrointestinal disorders.

World J Clin Pediatr. 2025-6-9

[3]
Efficacy and Safety of LBSC in Drug Induced Constipation Associated With Functional Gastrointestinal Disorder: A Double-Blind, Randomized, Interventional, Parallel, Controlled Trial a Clinical Study on LBSC for Drug Induced Constipation Associated With FGIDs.

Glob Adv Integr Med Health. 2024-9-17

[4]
One More Tool in the Tool Belt: A Qualitative Interview Study Investigating Patient and Clinician Opinions on the Integration of Psychometrics Into Routine Testing for Disorders of Gut-Brain Interaction.

Cureus. 2024-8-18

[5]
Role of social media in the presentation of disorders of gut-brain interaction: Review and recommendations.

J Gastroenterol Hepatol. 2024-11

[6]
Development and validation of the Alimetry Gut-Brain Wellbeing Survey: a novel patient-reported mental health scale for patients with chronic gastroduodenal symptoms.

Front Psychol. 2024-7-8

[7]
Treating disorders of brain-gut interaction with multidisciplinary integrated care. Moving towards a new standard of care.

JGH Open. 2024-5-20

[8]
It's a helluva journey: a qualitative study of patient and clinician experiences of nausea and vomiting syndromes.

Front Psychol. 2023-8-11

[9]
Recent Advances and Future Challenges in the Field of Digestive Diseases.

Medicina (Kaunas). 2023-1-20

本文引用的文献

[1]
Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors.

Dig Dis Sci. 2018-10-27

[2]
A Randomized Trial of a Group-Based Integrative Medicine Approach Compared to Waitlist Control on Irritable Bowel Syndrome Symptoms in Adults.

Explore (NY). 2018-11

[3]
Outcome of hospital outpatient treatment of functional gastrointestinal disorders.

Intern Med J. 2019-2

[4]
Multidisciplinary Treatment Reduces Pain and Increases Function in Children With Functional Gastrointestinal Disorders.

Clin Gastroenterol Hepatol. 2018-7-25

[5]
New treatments and therapeutic targets for IBS and other functional bowel disorders.

Nat Rev Gastroenterol Hepatol. 2018-10

[6]
Randomised controlled trials - the gold standard for effectiveness research: Study design: randomised controlled trials.

BJOG. 2018-12

[7]
Pilot-RCT of an integrative group therapy for patients with refractory irritable bowel syndrome (ISRCTN02977330).

J Psychosom Res. 2017-12-5

[8]
Functional Bowel Disorders: A Roadmap to Guide the Next Generation of Research.

Gastroenterology. 2017-12-27

[9]
The Prevalence and Impact of Overlapping Rome IV-Diagnosed Functional Gastrointestinal Disorders on Somatization, Quality of Life, and Healthcare Utilization: A Cross-Sectional General Population Study in Three Countries.

Am J Gastroenterol. 2017-11-14

[10]
Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome.

J Clin Med. 2017-10-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索